1. Home
  2. TDOC vs KURA Comparison

TDOC vs KURA Comparison

Compare TDOC & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teladoc Health Inc.

TDOC

Teladoc Health Inc.

HOLD

Current Price

$6.58

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Kura Oncology Inc.

KURA

Kura Oncology Inc.

HOLD

Current Price

$11.15

Market Cap

841.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TDOC
KURA
Founded
2002
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
841.6M
IPO Year
2015
2015

Fundamental Metrics

Financial Performance
Metric
TDOC
KURA
Price
$6.58
$11.15
Analyst Decision
Buy
Buy
Analyst Count
18
11
Target Price
$7.56
$25.56
AVG Volume (30 Days)
4.7M
1.5M
Earning Date
04-29-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
80.58
N/A
EPS
N/A
N/A
Revenue
$2,406,840,000.00
$67,482,000.00
Revenue This Year
$1.19
$28.28
Revenue Next Year
$1.25
$106.37
P/E Ratio
N/A
N/A
Revenue Growth
18.41
25.24
52 Week Low
$4.40
$5.45
52 Week High
$9.77
$12.49

Technical Indicators

Market Signals
Indicator
TDOC
KURA
Relative Strength Index (RSI) 56.48 70.82
Support Level $6.42 $8.80
Resistance Level $7.95 $11.17
Average True Range (ATR) 0.32 0.59
MACD -0.06 0.16
Stochastic Oscillator 28.76 86.05

Price Performance

Historical Comparison
TDOC
KURA

About TDOC Teladoc Health Inc.

Teladoc Health Inc is engaged in the provision of virtual healthcare services, connecting patients, providers, and healthcare systems through technology-enabled platforms. The company has two reportable segments: Integrated Care and BetterHelp. The Integrated Care segment provides virtual healthcare solutions, including primary care, mental health, chronic care management, and telehealth enablement services for employers, insurers, and healthcare systems, mainly on a business-to-business basis, while the BetterHelp segment offers direct-to-consumer online mental health services, including counseling and therapy delivered through digital platforms. It generates the majority of its revenue from the Integrated Care segment.

About KURA Kura Oncology Inc.

Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.

Share on Social Networks: